United States · Funded startup

Who invested in Nanoview Biosciences

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$2.5Mraised across 1 round since 2022, from 1 source

Latest round
Debt, $2.5MMar 2022
Investors
4
See who backed them

The rounds

  1. Mar 2022
    Debt$2.5M

    Source recordedSEC filing: $2.5M sold, first sale Feb 2022

Founders and team

From the SEC filings it signed: 2 on the team.

  • David FreedmanExecutive Officeri
  • Gerald WilliamsonExecutive Officer, Directori

On the board, as filediAndrea JacksonGeorge DaaboulParker Cassidy

Everyone who backed them

MassVenturesVC firm1round
Sands Capital VenturesPrivate equity1round
Northpond VenturesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Nanoview Biosciences

Who invested in Nanoview Biosciences?

Nanoview Biosciences's investors include National Science Foundation, MassVentures, Sands Capital Ventures and Northpond Ventures.

How much has Nanoview Biosciences raised?

Nanoview Biosciences has raised $2.5M across 1 round since 2022.

When did Nanoview Biosciences last raise?

Nanoview Biosciences's most recent round was a Debt of $2.5M in Mar 2022.

What was Nanoview Biosciences's biggest round?

Its most recent round, $2.5M in Mar 2022, is also its largest on record.

Who backed Nanoview Biosciences first?

Nanoview Biosciences's first round on record, in Mar 2022, was backed by National Science Foundation, MassVentures and Sands Capital Ventures and 1 others.

What stage is Nanoview Biosciences at?

Nanoview Biosciences's latest named round is a Debt, in Mar 2022.

Where is Nanoview Biosciences based?

Nanoview Biosciences is based in the United States.

Companies like Nanoview Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.